Product Information

CYCLOSPORINE 0.05% EYE EMULSION is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.9240 per EA under NDC 00480407660. Its NADAC has been published 37 times since Dec 10, 2025.

FDA first approved this application on Dec 14, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CYCLOSPORINE 0.05% EYE EMULSION

Cyclosporine
$0.9240per EA

Strength

.5 mg/mL

NDC

00480407660

Classification

Generic

Dosage Form

EMULSION

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

CYCLOSPORINE

Approval Type

Generic (ANDA)

FDA Application

ANDA203880

FDA Approved

12/14/2023

TE Code

AB

On Market Since

10/28/2025

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CYCLOSPORINE 0.05% EYE EMULSION has been published 37 times since Dec 10, 2025, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9240 per EA
All-time high$1.9090 (Dec 10, 2025)
All-time low$0.9240 (Aug 19, 2026)
52-week high$1.9090
52-week low$0.9240
Median price$1.4790
Average price$1.4173
Largest weekly change-11.2% (Jul 22, 2026)
Weeks tracked37
Tracking sinceDec 10, 2025

Price History

1W

-3.9%

1M

-3.9%

3M

-24.0%

6M

-42.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-51.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CYCLOSPORINE 0.05% EYE EMULSION?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE 0.05% EYE EMULSION, manufactured by Teva Pharmaceuticals USA Inc., is $0.9240 per EA (NDC 00480407660), effective Aug 19, 2026.

How has the price of CYCLOSPORINE 0.05% EYE EMULSION changed over time?

Over the history we have for it, the NADAC for CYCLOSPORINE 0.05% EYE EMULSION has declined 51.6%. It has been tracked across 37 weekly CMS publications since Dec 10, 2025.

What are the highest and lowest recorded NADAC prices for CYCLOSPORINE 0.05% EYE EMULSION?

Since Dec 10, 2025, the NADAC for CYCLOSPORINE 0.05% EYE EMULSION has ranged from a low of $0.9240 (Aug 19, 2026) to a high of $1.9090 (Dec 10, 2025), with a median of $1.4790 per EA.

Are there cheaper alternatives to CYCLOSPORINE 0.05% EYE EMULSION?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOSPORINE 0.05% EYE EMULSION in a comparable dosage form, but none are currently priced below it.

Who manufactures CYCLOSPORINE 0.05% EYE EMULSION?

CYCLOSPORINE 0.05% EYE EMULSION (NDC 00480407660) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.